BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 12036209)

  • 1. Predominance of IgG1 and IgG3 subclasses of autoantibodies to neutrophil cytoplasmic antigens in patients with systemic lupus erythematosus.
    Manolova I; Dancheva M; Halacheva K
    Rheumatol Int; 2002 Apr; 21(6):227-33. PubMed ID: 12036209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antineutrophil cytoplasmic antibodies in patients with systemic lupus erythematosus: prevalence, antigen specificity, and clinical associations.
    Manolova I; Dancheva M; Halacheva K
    Rheumatol Int; 2001 Jul; 20(5):197-204. PubMed ID: 11518040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-neutrophil cytoplasm antibody IgG subclasses in Wegener's granulomatosis: a possible pathogenic role for the IgG4 subclass.
    Holland M; Hewins P; Goodall M; Adu D; Jefferis R; Savage CO
    Clin Exp Immunol; 2004 Oct; 138(1):183-92. PubMed ID: 15373923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection rate and antigenic specificities of antineutrophil cytoplasmic antibodies in chinese patients with clinically suspected vasculitis.
    Xin G; Zhao MH; Wang HY
    Clin Diagn Lab Immunol; 2004 May; 11(3):559-62. PubMed ID: 15138182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoglobulin isotypes of anti-myeloperoxidase and anti-lactoferrin antibodies in patients with collagen diseases.
    Chikazawa H; Nishiya K; Matsumori A; Hashimoto K
    J Clin Immunol; 2000 Jul; 20(4):279-86. PubMed ID: 10939715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-neutrophil cytoplasmic antibodies in 566 European patients with systemic lupus erythematosus: prevalence, clinical associations and correlation with other autoantibodies. European Concerted Action on the Immunogenetics of SLE.
    Galeazzi M; Morozzi G; Sebastiani GD; Bellisai F; Marcolongo R; Cervera R; De Ramòn Garrido E; Fernandez-Nebro A; Houssiau F; Jedryka-Goral A; Mathieu A; Papasteriades C; Piette JC; Scorza R; Smolen J
    Clin Exp Rheumatol; 1998; 16(5):541-6. PubMed ID: 9779300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of immunofluorescence to the identification and characterization of anti-neutrophil cytoplasmic autoantibodies. The role of different fixatives.
    Radice A; Vecchi M; Bianchi MB; Sinico RA
    Clin Exp Rheumatol; 2000; 18(6):707-12. PubMed ID: 11138332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IgG from myeloperoxidase-antineutrophil cytoplasmic antibody-positive patients stimulates greater activation of primed neutrophils than IgG from proteinase 3-antineutrophil cytosplasmic antibody-positive patients.
    Harper L; Radford D; Plant T; Drayson M; Adu D; Savage CO
    Arthritis Rheum; 2001 Apr; 44(4):921-30. PubMed ID: 11315931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-lactoferrin antibodies in systemic lupus erythematosus: isotypes and clinical correlates.
    Caccavo D; Rigon A; Picardi A; Galluzzo S; Vadacca M; Ferri GM; Amoroso A; Afeltra A
    Clin Rheumatol; 2005 Aug; 24(4):381-7. PubMed ID: 15592902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of anti-neutrophil cytoplasmic antibodies (ANCA): frequency and specificity in a sample of 191 homozygous (PiZZ) alpha1-antitrypsin-deficient subjects.
    Audrain MA; Sesboüé R; Baranger TA; Elliott J; Testa A; Martin JP; Lockwood CM; Esnault VL
    Nephrol Dial Transplant; 2001 Jan; 16(1):39-44. PubMed ID: 11208991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ANCA and IgG subclasses.
    Segelmark M; Wieslander J
    Adv Exp Med Biol; 1993; 336():71-5. PubMed ID: 8296678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibodies to selected minor target antigens in patients with anti-neutrophil cytoplasmic antibodies (ANCA).
    Talor MV; Stone JH; Stebbing J; Barin J; Rose NR; Burek CL
    Clin Exp Immunol; 2007 Oct; 150(1):42-8. PubMed ID: 17614969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-myeloperoxidase IgG subclass distribution and avidity in sera from patients with propylthiouracil-induced antineutrophil cytoplasmic antibodies associated vasculitis.
    Gao Y; Ye H; Yu F; Guo XH; Zhao MH
    Clin Immunol; 2005 Oct; 117(1):87-93. PubMed ID: 16019262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-neutrophil cytoplasmic antibodies in patients with chronic liver diseases: prevalence, antigen specificity and predictive value for diagnosis of autoimmune liver disease. Swedish Internal Medicine Liver Club (SILK).
    Lindgren S; Nilsson S; Nässberger L; Verbaan H; Wieslander J
    J Gastroenterol Hepatol; 2000 Apr; 15(4):437-42. PubMed ID: 10824890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical associations and characterisation of antineutrophil cytoplasmic antibodies directed against bactericidal/permeability-increasing protein and azurocidin.
    Cooper T; Savige J; Nassis L; Paspaliaris B; Neeson P; Neil J; Knight KR; Daskalakis M; Doery JC
    Rheumatol Int; 2000; 19(4):129-36. PubMed ID: 10836522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Level and avidity of antineutrophil cytoplasmic antibodies specific to lactoferrin are useful biomarkers in systemic lupus erythematosus.
    Gajic-Veljic M; Lekic B; Nikolic M; Lalosevic J; Stojimirovic B; Bonaci-Nikolic B
    Clin Rheumatol; 2022 Mar; 41(3):709-720. PubMed ID: 34618258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A review of immunofluorescent patterns associated with antineutrophil cytoplasmic antibodies (ANCA) and their differentiation from other antibodies.
    Savige JA; Paspaliaris B; Silvestrini R; Davies D; Nikoloutsopoulos T; Sturgess A; Neil J; Pollock W; Dunster K; Hendle M
    J Clin Pathol; 1998 Aug; 51(8):568-75. PubMed ID: 9828813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antineutrophil cytoplasm autoantibodies against bactericidal/permeability-increasing protein in inflammatory bowel disease.
    Walmsley RS; Zhao MH; Hamilton MI; Brownlee A; Chapman P; Pounder RE; Wakefield AJ; Lockwood CM
    Gut; 1997 Jan; 40(1):105-9. PubMed ID: 9155585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bactericidal/permeability-increasing protein and cathepsin G are the major antigenic targets of antineutrophil cytoplasmic autoantibodies in systemic sclerosis.
    Khanna D; Aggarwal A; Bhakuni DS; Dayal R; Misra R
    J Rheumatol; 2003 Jun; 30(6):1248-52. PubMed ID: 12784398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antineutrophil cytoplasmic autoantibodies (ANCA) in children with cystic fibrosis.
    Sedivá A; Bartůnková J; Kolárová I; Hrusák O; Vávrová V; Macek M; Lockwood CM; Dunn AC
    J Autoimmun; 1998 Apr; 11(2):185-90. PubMed ID: 9650098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.